- Release Date: 10/12/24 09:58
- Summary: Phase 2 Stroke Clinical Trial Update
- Price Sensitive: Yes
- Download Document 287.63KB
- Forums
- ASX - By Stock
- Ann: Phase 2 Stroke Clinical Trial Update
AGN
argenica therapeutics limited
Add to My Watchlist
5.04%
!
73.0¢

Ann: Phase 2 Stroke Clinical Trial Update
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
73.0¢ |
Change
0.035(5.04%) |
Mkt cap ! $94.41M |
Open | High | Low | Value | Volume |
71.0¢ | 74.5¢ | 70.5¢ | $165.6K | 227.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2311 | 72.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.0¢ | 19409 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2311 | 0.725 |
2 | 68 | 0.720 |
2 | 61 | 0.715 |
2 | 7112 | 0.710 |
1 | 28000 | 0.705 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 19409 | 1 |
0.735 | 16652 | 2 |
0.740 | 24717 | 1 |
0.750 | 5000 | 1 |
0.760 | 2631 | 1 |
Last trade - 14.24pm 11/08/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online